COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme
Laboratory tests for the accurate and rapid identification of SARS-CoV-2 variants can potentially guide the treatment of COVID-19 patients and inform infection control and public health surveillance efforts. Here, we present the development and validation of a rapid COVID-19 variant DETECTR assay incorporating loop-mediated isothermal amplification (LAMP) followed by CRISPR-Cas12 based identification of single nucleotide polymorphism (SNP) mutations in the SARS-CoV-2 spike (S) gene. This assay targets the L452R, E484K/Q/A, and N501Y mutations, at least one of which is found in nearly all major variants. In a comparison of three different Cas12 enzymes, only the newly identified enzyme CasDx1 was able to accurately identify all targeted SNP mutations. An analysis pipeline for CRISPR-based SNP identification from 261 clinical samples yielded a SNP concordance of 97.3% and agreement of 98.9% (258 of 261) for SARS-CoV-2 lineage classification, using SARS-CoV-2 whole-genome sequencing and/or real-time RT-PCR as test comparators. We also showed that detection of the single E484A mutation was necessary and sufficient to accurately identify Omicron from other major circulating variants in patient samples. These findings demonstrate the utility of CRISPR-based DETECTR as a faster and simpler diagnostic method compared with sequencing for SARS-CoV-2 variant identification in clinical and public health laboratories.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Journal of clinical microbiology - 60(2022), 7 vom: 20. Juli, Seite e0026122 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fasching, Clare L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Assay validation |
|---|
| Anmerkungen: |
Date Completed 22.07.2022 Date Revised 07.09.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1128/jcm.00261-22 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342873733 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342873733 | ||
| 003 | DE-627 | ||
| 005 | 20231226015121.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1128/jcm.00261-22 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1142.xml |
| 035 | |a (DE-627)NLM342873733 | ||
| 035 | |a (NLM)35766492 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fasching, Clare L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.07.2022 | ||
| 500 | |a Date Revised 07.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Laboratory tests for the accurate and rapid identification of SARS-CoV-2 variants can potentially guide the treatment of COVID-19 patients and inform infection control and public health surveillance efforts. Here, we present the development and validation of a rapid COVID-19 variant DETECTR assay incorporating loop-mediated isothermal amplification (LAMP) followed by CRISPR-Cas12 based identification of single nucleotide polymorphism (SNP) mutations in the SARS-CoV-2 spike (S) gene. This assay targets the L452R, E484K/Q/A, and N501Y mutations, at least one of which is found in nearly all major variants. In a comparison of three different Cas12 enzymes, only the newly identified enzyme CasDx1 was able to accurately identify all targeted SNP mutations. An analysis pipeline for CRISPR-based SNP identification from 261 clinical samples yielded a SNP concordance of 97.3% and agreement of 98.9% (258 of 261) for SARS-CoV-2 lineage classification, using SARS-CoV-2 whole-genome sequencing and/or real-time RT-PCR as test comparators. We also showed that detection of the single E484A mutation was necessary and sufficient to accurately identify Omicron from other major circulating variants in patient samples. These findings demonstrate the utility of CRISPR-based DETECTR as a faster and simpler diagnostic method compared with sequencing for SARS-CoV-2 variant identification in clinical and public health laboratories | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a CRISPR-Cas12 | |
| 650 | 4 | |a DETECTR | |
| 650 | 4 | |a LAMP | |
| 650 | 4 | |a SARS coronavirus 2 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a assay validation | |
| 650 | 4 | |a guide RNAs | |
| 650 | 4 | |a variant | |
| 650 | 4 | |a viral mutations | |
| 700 | 1 | |a Servellita, Venice |e verfasserin |4 aut | |
| 700 | 1 | |a McKay, Bridget |e verfasserin |4 aut | |
| 700 | 1 | |a Nagesh, Vaishnavi |e verfasserin |4 aut | |
| 700 | 1 | |a Broughton, James P |e verfasserin |4 aut | |
| 700 | 1 | |a Sotomayor-Gonzalez, Alicia |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Baolin |e verfasserin |4 aut | |
| 700 | 1 | |a Brazer, Noah |e verfasserin |4 aut | |
| 700 | 1 | |a Reyes, Kevin |e verfasserin |4 aut | |
| 700 | 1 | |a Streithorst, Jessica |e verfasserin |4 aut | |
| 700 | 1 | |a Deraney, Rachel N |e verfasserin |4 aut | |
| 700 | 1 | |a Stanfield, Emma |e verfasserin |4 aut | |
| 700 | 1 | |a Hendriks, Carley G |e verfasserin |4 aut | |
| 700 | 1 | |a Fung, Becky |e verfasserin |4 aut | |
| 700 | 1 | |a Miller, Steve |e verfasserin |4 aut | |
| 700 | 1 | |a Ching, Jesus |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Janice S |e verfasserin |4 aut | |
| 700 | 1 | |a Chiu, Charles Y |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical microbiology |d 1975 |g 60(2022), 7 vom: 20. Juli, Seite e0026122 |w (DE-627)NLM000005460 |x 1098-660X |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2022 |g number:7 |g day:20 |g month:07 |g pages:e0026122 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1128/jcm.00261-22 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2022 |e 7 |b 20 |c 07 |h e0026122 | ||